Although the link between ALS pathology and BBB dysfunction is not clear, transgenic rodents expressing human SOD1 mutations develop a leaky BBB with higher permeability, enlarged astrocytic end-feet, and an interrupted basement membrane associated with a reduction of BMEC-like cells and astrocytes, thus leading to oedema and microbleeds. Here, SOD1 is linked to amyotrophic lateral sclerosis.